Guggenheim analyst Seamus Fernandez raised the firm’s price target on Apogee Therapeutics (APGE) to $110 from $95 and keeps a Buy rating on the sha...
网页链接Guggenheim analyst Seamus Fernandez raised the firm’s price target on Apogee Therapeutics (APGE) to $110 from $95 and keeps a Buy rating on the sha...
网页链接
精彩评论